TR200201146T2 - Sertralin hidrokorid polimorfik formları. - Google Patents
Sertralin hidrokorid polimorfik formları.Info
- Publication number
- TR200201146T2 TR200201146T2 TR2002/01146T TR200201146T TR200201146T2 TR 200201146 T2 TR200201146 T2 TR 200201146T2 TR 2002/01146 T TR2002/01146 T TR 2002/01146T TR 200201146 T TR200201146 T TR 200201146T TR 200201146 T2 TR200201146 T2 TR 200201146T2
- Authority
- TR
- Turkey
- Prior art keywords
- sertraline
- hydrocoride
- sertraline hydrochloride
- polymorphic forms
- polymorphic
- Prior art date
Links
- VGKDLMBJGBXTGI-SJCJKPOMSA-N sertraline Chemical compound C1([C@@H]2CC[C@@H](C3=CC=CC=C32)NC)=CC=C(Cl)C(Cl)=C1 VGKDLMBJGBXTGI-SJCJKPOMSA-N 0.000 title 1
- 229960002073 sertraline Drugs 0.000 title 1
- GLQPTZAAUROJMO-UHFFFAOYSA-N 4-(3,4-dimethoxyphenyl)benzaldehyde Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC=C(C=O)C=C1 GLQPTZAAUROJMO-UHFFFAOYSA-N 0.000 abstract 3
- 229960003660 sertraline hydrochloride Drugs 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 239000013078 crystal Substances 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
- C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
- C07C211/42—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99810981 | 1999-10-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200201146T2 true TR200201146T2 (tr) | 2004-12-21 |
Family
ID=8243113
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2002/01146T TR200201146T2 (tr) | 1999-10-29 | 2000-10-23 | Sertralin hidrokorid polimorfik formları. |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US6872853B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1224160B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2003513062A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1384816A (cg-RX-API-DMAC7.html) |
| AR (1) | AR026293A1 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE409684T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU1386301A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2387135A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE60040406D1 (cg-RX-API-DMAC7.html) |
| HU (1) | HUP0203559A3 (cg-RX-API-DMAC7.html) |
| IL (2) | IL149050A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA02004255A (cg-RX-API-DMAC7.html) |
| MY (1) | MY141509A (cg-RX-API-DMAC7.html) |
| TR (1) | TR200201146T2 (cg-RX-API-DMAC7.html) |
| TW (1) | TWI260315B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2001032601A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200203254B (cg-RX-API-DMAC7.html) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1630156A1 (en) * | 1998-11-27 | 2006-03-01 | Teva Pharmaceutical Industries Ltd | Sertraline hydrochloride polymorphs |
| IL143311A0 (en) * | 1998-11-27 | 2002-04-21 | Teva Pharma | Sertraline hydrochloride polymorphs |
| US6500987B1 (en) * | 1998-11-27 | 2002-12-31 | Teva Pharmaceutical Industries Ltd. | Sertraline hydrochloride polymorphs |
| US6495721B1 (en) | 1999-08-09 | 2002-12-17 | Teva Pharmaceutical Industries Ltd. | Sertraline hydrochloride Form II and methods for the preparation thereof |
| US20050119351A1 (en) * | 1999-10-29 | 2005-06-02 | Van Der Schaaf Paul A. | Polymorphic forms of sertraline hydrochloride |
| US7442838B2 (en) * | 1999-10-29 | 2008-10-28 | Ciba Specialty Chemicals Corp. | Polymorphic forms of sertraline hydrochloride |
| EP1774965A3 (en) * | 1999-12-21 | 2007-10-10 | Teva Pharmaceutical Industries Ltd | Novel sertraline hydrochloride polymorph, processes for preparing them, compositions containing them and methods of using them |
| YU47902A (sh) * | 1999-12-21 | 2005-11-28 | Teva Pharmaceutical Industries Ltd. | Novi polimorfi sertralin hidrohlorida, postupci za njihovo dobijanje, preparati koji ih sadrže i postupci za njihovu upotrebu |
| IN192343B (cg-RX-API-DMAC7.html) * | 2000-05-26 | 2004-04-10 | Ranbaxy Lab Ltd | |
| US7067700B2 (en) | 2001-05-31 | 2006-06-27 | Fermion Oy | Process for preparing sertraline hydrochloride polymorphic form II |
| EP1499581A1 (en) | 2002-04-29 | 2005-01-26 | Teva Pharmaceutical Industries Ltd. | Process for preparation of polymorphic form ii of sertraline hydrochloride, pharmaceutical formulations and methods of administration thereof |
| CN102215522A (zh) * | 2002-06-27 | 2011-10-12 | 美商内数位科技公司 | 宽频码分多址第一无线网络控制器 |
| JP2007502329A (ja) | 2003-05-23 | 2007-02-08 | トランスフォーム・ファーマシューティカルズ・インコーポレイテッド | セルトラリン組成物 |
| CA2544684A1 (en) | 2003-11-04 | 2005-05-26 | Cipla Limited | Process for the preparation of polymorphs of selective serotonin reuptake inhibitor |
| EP1711493A2 (en) * | 2004-02-06 | 2006-10-18 | CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement | Crystalline forms of zolmitriptan |
| EP1893559A2 (en) * | 2005-06-09 | 2008-03-05 | Teva Pharmaceutical Industries Ltd | Process for preparation of sertraline hydrochloride form i |
| US7518019B2 (en) | 2006-06-01 | 2009-04-14 | Hetero Drugs Limited | Processes for preparing sertraline hydrochloride crystalline forms |
| CA2594198A1 (en) * | 2007-07-20 | 2009-01-20 | Apotex Pharmachem Inc. | A novel process for the preparation of sertraline hydrochloride form ii |
| US9993793B2 (en) | 2010-04-28 | 2018-06-12 | The Procter & Gamble Company | Delivery particles |
| US9186642B2 (en) | 2010-04-28 | 2015-11-17 | The Procter & Gamble Company | Delivery particle |
| US8980292B2 (en) | 2011-04-07 | 2015-03-17 | The Procter & Gamble Company | Conditioner compositions with increased deposition of polyacrylate microcapsules |
| WO2012138710A2 (en) | 2011-04-07 | 2012-10-11 | The Procter & Gamble Company | Personal cleansing compositions with increased deposition of polyacrylate microcapsules |
| US8927026B2 (en) | 2011-04-07 | 2015-01-06 | The Procter & Gamble Company | Shampoo compositions with increased deposition of polyacrylate microcapsules |
| CN105061217A (zh) * | 2015-06-30 | 2015-11-18 | 徐静 | 枸橼酸舍曲林的2种晶型及其制备方法 |
| EP4229164A1 (en) | 2020-10-16 | 2023-08-23 | The Procter & Gamble Company | Consumer product compositions with at least two encapsulate populations |
| JP7719177B2 (ja) | 2020-10-16 | 2025-08-05 | ザ プロクター アンド ギャンブル カンパニー | 封入体の集団を含む消費者製品組成物 |
| US12486478B2 (en) | 2020-10-16 | 2025-12-02 | The Procter & Gamble Company | Consumer products comprising delivery particles with high core:wall ratios |
| CN112552188B (zh) * | 2020-12-17 | 2023-07-28 | 山西仟源医药集团股份有限公司 | 盐酸舍曲林晶型i的制备方法 |
| CN113588626B (zh) * | 2021-08-24 | 2024-05-24 | 上海师范大学 | 一种苯丙氨酸对映体的拉曼光谱检测方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4536518A (en) | 1979-11-01 | 1985-08-20 | Pfizer Inc. | Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine |
| US5082970A (en) | 1991-03-06 | 1992-01-21 | Pfizer Inc. | Process for recycling amine isomer |
| GB9114947D0 (en) | 1991-07-11 | 1991-08-28 | Pfizer Ltd | Process for preparing sertraline |
| US5248699A (en) * | 1992-08-13 | 1993-09-28 | Pfizer Inc. | Sertraline polymorph |
| US5734083A (en) * | 1996-05-17 | 1998-03-31 | Torcan Chemical Ltd. | Sertraline polymorph |
| HU222341B1 (hu) | 1996-12-18 | 2003-06-28 | Richter Gedeon Vegyészeti Gyár Rt. | Eljárás sertralin előállítására és az eljárásban alkalmazott intermedier |
| DE69713353D1 (de) * | 1997-12-11 | 2002-07-18 | Torcan Chemical Ltd | Sertralin-Polymorph mit verbesserter Wasserlöslichkeit |
| CA2323629A1 (en) | 1998-03-18 | 1999-09-23 | Ciba Specialty Chemicals Holding Inc. | Process for the cis-selective catalytic hydrogenation of cyclohexylidenamines |
| JP2000026378A (ja) | 1998-07-03 | 2000-01-25 | Sumika Fine Chemicals Co Ltd | 塩酸セルトラリンの製法 |
| US6500987B1 (en) | 1998-11-27 | 2002-12-31 | Teva Pharmaceutical Industries Ltd. | Sertraline hydrochloride polymorphs |
| IL143311A0 (en) * | 1998-11-27 | 2002-04-21 | Teva Pharma | Sertraline hydrochloride polymorphs |
| US6495721B1 (en) | 1999-08-09 | 2002-12-17 | Teva Pharmaceutical Industries Ltd. | Sertraline hydrochloride Form II and methods for the preparation thereof |
| YU47902A (sh) | 1999-12-21 | 2005-11-28 | Teva Pharmaceutical Industries Ltd. | Novi polimorfi sertralin hidrohlorida, postupci za njihovo dobijanje, preparati koji ih sadrže i postupci za njihovu upotrebu |
-
2000
- 2000-10-07 TW TW089120975A patent/TWI260315B/zh not_active IP Right Cessation
- 2000-10-20 MY MYPI20004969A patent/MY141509A/en unknown
- 2000-10-23 JP JP2001534755A patent/JP2003513062A/ja not_active Withdrawn
- 2000-10-23 WO PCT/EP2000/010416 patent/WO2001032601A1/en not_active Ceased
- 2000-10-23 IL IL14905000A patent/IL149050A0/xx active IP Right Grant
- 2000-10-23 HU HU0203559A patent/HUP0203559A3/hu unknown
- 2000-10-23 US US10/111,947 patent/US6872853B1/en not_active Expired - Fee Related
- 2000-10-23 AT AT00975896T patent/ATE409684T1/de not_active IP Right Cessation
- 2000-10-23 TR TR2002/01146T patent/TR200201146T2/xx unknown
- 2000-10-23 DE DE60040406T patent/DE60040406D1/de not_active Expired - Fee Related
- 2000-10-23 AU AU13863/01A patent/AU1386301A/en not_active Abandoned
- 2000-10-23 MX MXPA02004255A patent/MXPA02004255A/es active IP Right Grant
- 2000-10-23 CN CN00815052A patent/CN1384816A/zh active Pending
- 2000-10-23 CA CA002387135A patent/CA2387135A1/en not_active Abandoned
- 2000-10-23 EP EP00975896A patent/EP1224160B1/en not_active Expired - Lifetime
- 2000-10-27 AR ARP000105711A patent/AR026293A1/es not_active Application Discontinuation
-
2002
- 2002-04-09 IL IL149050A patent/IL149050A/en not_active IP Right Cessation
- 2002-04-24 ZA ZA200203254A patent/ZA200203254B/xx unknown
-
2003
- 2003-12-15 US US10/736,195 patent/US6939992B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US6939992B2 (en) | 2005-09-06 |
| DE60040406D1 (de) | 2008-11-13 |
| ATE409684T1 (de) | 2008-10-15 |
| AU1386301A (en) | 2001-05-14 |
| EP1224160A1 (en) | 2002-07-24 |
| US20040132828A1 (en) | 2004-07-08 |
| MY141509A (en) | 2010-05-14 |
| HUP0203559A3 (en) | 2008-01-28 |
| HUP0203559A2 (hu) | 2003-03-28 |
| ZA200203254B (en) | 2003-07-22 |
| IL149050A (en) | 2007-03-08 |
| MXPA02004255A (es) | 2002-10-17 |
| TWI260315B (en) | 2006-08-21 |
| CA2387135A1 (en) | 2001-05-10 |
| AR026293A1 (es) | 2003-02-05 |
| WO2001032601A1 (en) | 2001-05-10 |
| IL149050A0 (en) | 2002-11-10 |
| CN1384816A (zh) | 2002-12-11 |
| JP2003513062A (ja) | 2003-04-08 |
| EP1224160B1 (en) | 2008-10-01 |
| US6872853B1 (en) | 2005-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY141509A (en) | Polymoprphic forms of sertraline hydrochloride | |
| UY27304A1 (es) | Inhibidores del factor inhibidor de la migración de los macrófagos y métodos para su identificación | |
| PA8501801A1 (es) | Inhibidores triciclicos de polimerasas (adp - polirribosas) | |
| BR0307351A (pt) | Composto, composição farmacêutica, método para tratar uma condição ou estado de doença mediados pela atividade de p38 quinase ou mediados por citocinas produzidas pela atividade de p38 quinase, uso de um composto, e, processo para preparar um composto | |
| ECSP056020A (es) | Inhibidores del factor inhibidor de la migración de los macrofagos y metodos para su identificacion | |
| PT915898E (pt) | Forma i cristalina de claritromicina | |
| ES2213732T3 (es) | Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos. | |
| BR0316375A (pt) | Diazinopirimidinas | |
| BR0008958A (pt) | Inibidores de reabsorção de monoamina para otratamento de distúrbios do snc | |
| ES2170732B2 (es) | Procedimiento para preparar citalopram purificado | |
| IL183244A0 (en) | Process for the preparation of 1-amino-3,5-dimethyladamantane hydrochloride | |
| ATE277039T1 (de) | Farnesyltransferase-inhibitoren die eine pyrrolstruktur haben und verfahren zu ihrer herstellung | |
| EP1208092A4 (en) | SULPHONAMIDES AS MATRIX METALLOPROTEINASE INHIBITORS | |
| ECSP044973A (es) | Nuevas formas polimorficas cristalinas de clorhidrato de lercanidipina y proceso para su preparacion | |
| AR036137A1 (es) | Sales novedosas de derivados anticonvulsivos | |
| NO20031743L (no) | Krystallinsk venlafaxinbase og nye polyformer av venlafaxin- hydroklorid, samt fremgangsmåte for fremstilling derav | |
| IT1319234B1 (it) | Processo di preparazione di gabapentina. | |
| IT1318535B1 (it) | Processo per la preparazione di sali farmaceuticamente accettabili di(ss,rs)-s-adenosil-l-metionina. | |
| ES2185967T3 (es) | Procedimiento para preparar derivados acidos beta-amino-alfa-hidroxi. | |
| FI980530L (fi) | Menetelmä N-bis-(2-(1,2-dikarboksietoksi)-etyyli)amiinijohdannaisen va lmistamiseksi, menetelmällä saatavat tuotteet sekä niiden käytöt | |
| TR200200473T2 (tr) | Rar selektif retinoid agonistleri. | |
| BR0314838A (pt) | Sistema de liberação controlada, e, processo para preparar comprimidos de liberação controlada de temozolomida | |
| BR0113259A (pt) | Processo para a preparação de um composto, composto e processo para a preparação de compostos | |
| ATE552234T1 (de) | Cyclohexanderivate und verfahren zu deren herstellung | |
| BR0010961A (pt) | Composto, composição farmacêutica, e, métodos para tratar epilepsia, ataques de tontura, hipocinésia, e distúrbios cranianos, distúrbios neurodegenerativos, depressão, ansiedade, pânico, dor, distúrbios neuropatológicos e distúrbios do sono |